| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |